OTC/Supplement Combinations "Serious Concern" For FDA
This article was originally published in The Tan Sheet
Executive Summary
The appropriateness of combination products containing OTC drug and dietary supplement ingredients is under review at FDA. In the interim, the agency is discouraging firms from marketing such items.
You may also be interested in...
Congress Presses FDA To Speak Up On OTC/Supplement Combo Products
Congressional interest turns up the pressure on FDA to make a statement on Bayer Aspirin with Heart Advantage, and issue a definitive policy on any products that combine dietary supplement and OTC drug ingredients
Congress Presses FDA To Speak Up On OTC/Supplement Combo Products
Congressional interest turns up the pressure on FDA to make a statement on Bayer Aspirin with Heart Advantage, and issue a definitive policy on any products that combine dietary supplement and OTC drug ingredients
Congress Presses FDA To Speak Up On OTC/Supplement Combo Products
Congressional interest turns up the pressure on FDA to make a statement on Bayer Aspirin with Heart Advantage, and issue a definitive policy on any products that combine dietary supplement and OTC drug ingredients